WC
NAUT icon

Wexford Capital’s Nautilus Biotechnolgy NAUT Stock Holding History

Wexford Capital’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-104,580
Closed -$90K – 293
2025
Q1 		$90K Sell
104,580
-220,659
-68% -$328K 0.02% 204
2024
Q4 		$546K Buy
325,239
+96,889
+42% +$232K 0.09% 94
2024
Q3 		$651K Buy
228,350
+20,000
+10% +$51.8K 0.16% 88
2024
Q2 		$488K Buy
208,350
+49,249
+31% +$129K 0.12% 115
2024
Q1 		$468K Buy
+159,101
New +$451K 0.1% 133

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Wexford Capital's NAUT Position: Q2 2025 in Review

Wexford Capital sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 104,580 shares — an estimated $90K sold.

Wexford Capital first reported a position in NAUT in Q1 2024 and held it in 5 quarters. The position peaked at $651K in Q3 2024. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • Wexford Capital reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • Wexford Capital sold 104,580 Nautilus Biotechnolgy shares in Q2 2025, an estimated $90K.
  • Wexford Capital first reported a position in Nautilus Biotechnolgy in Q1 2024 and held it in 5 quarters.
  • Wexford Capital's Nautilus Biotechnolgy position peaked at $651K in Q3 2024.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on Wexford Capital's 13F filing for Q2 2025, filed 14 Aug 2025.